Bing-Mae Chen
- Molecular Biology
- Biomaterials top 2%
- Biomedical Engineering
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Co-authors
- Steve R. RofflerTian‐Lu ChengYu-Cheng SuKai‐Hsiang ChuangPierre‐Alain BurnoufChien‐Hsiun ChenChia-Jung ChangYuan-Tsong Chen
- Topics
- Nanoparticle-Based Drug Delivery (11 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- TaiwanUnited StatesIsrael
In The Last Decade
Bing-Mae Chen
20 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 516
- Biomaterials 440
- Biomedical Engineering 252
- Radiology, Nuclear Medicine and Imaging 247
- Immunology 233
Countries citing papers authored by Bing-Mae Chen
This map shows the geographic impact of Bing-Mae Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing-Mae Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing-Mae Chen more than expected).
Fields of papers citing papers by Bing-Mae Chen
This network shows the impact of papers produced by Bing-Mae Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing-Mae Chen. The network helps show where Bing-Mae Chen may publish in the future.
Co-authorship network of co-authors of Bing-Mae Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Bing-Mae Chen. A scholar is included among the top collaborators of Bing-Mae Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing-Mae Chen. Bing-Mae Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 95 | |
| 3 | 15 | |
| 4 | 93 | |
| 5 | 68 | |
| 6 | 25 | |
| 7 | 56 | |
| 8 | 39 | |
| 9 | 183 | |
| 10 | 32 | |
| 11 | 50 | |
| 12 | 14 | |
| 13 | 103 | |
| 14 | 32 | |
| 15 | 79 | |
| 16 | 75 | |
| 17 | 13 | |
| 18 | 76 | |
| 19 | 16 | |
| 20 | 21 |
About Bing-Mae Chen
Bing-Mae Chen is a scholar working on Biomaterials, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Biomaterials (440 citations), Pharmaceutical Science (89 citations) and Immunology (233 citations). Bing-Mae Chen has collaborated with scholars based in Taiwan, United States and Israel. Frequent co-authors include Steve R. Roffler, Tian‐Lu Cheng, Yu-Cheng Su, Kai‐Hsiang Chuang, Pierre‐Alain Burnouf, Chien‐Hsiun Chen, Chia-Jung Chang, Yuan-Tsong Chen, Kuo‐Hsiang Chuang and Jer-Yuarn Wu. Their work appears in journals such as Nature Communications, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.